Pharmafile Logo

How does funding flow in NHSE Regions? – Live Webinar

On Friday 23rd February at 2.00pm, we will sit down with guest speaker Richard Smale (Interim Director of System Co-ordination, NHS England [NHSE] – South West) for an all-encompassing discussion to explore finance, funding flows, system priorities, and the decision-making process in NHS Regions.

Which decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and engage with Region leaders?

Join guest speaker Richard Smale (Interim Director of System Co-ordination, NHS England [NHSE] – South West) for an all-encompassing discussion to explore finance, funding flows, system priorities, and the decision-making process in NHS Regions. Register now for this live webinar on Friday 23rd February at 2.00pm. Learn more and register here to join us live.

Richard heads up system co-ordination work across the NHS South West Region. With NHSE regions becoming increasingly prominent, not least in the new specialised commissioning systems, we look forward to hearing Richard’s views on funding flows, system management and decision-making at this level.

The webinar will be led by David Thorne (Principal Consultant, Mtech Access and Transformation Director at Well Up North Primary Care Network [PCN]) who will put both the NHS and industry perspectives to Richard to explore the real state of the NHS.

In this webinar, David and Richard will discuss:

  • Where the NHS is heading and what this means for your strategy and business planning
  • Decision making, finances, and funding flows across the NHS
  • The role of NHS Regions, particularly with key funding decisions like Specialised Commissioning
  • Delivering service change across integrated systems
  • Policy priorities in practice and what to expect in an election year
  • How Pharma, Medtech, and Diagnostics companies can best engage NHS leaders at Region level

If you cannot attend the webinar but would like to know more, please register nonetheless, as all registrants will receive a recording of the webinar.

The webinar is free and open to all market access, patient access, field-based, and other healthcare professional ‑facing teams in Pharmaceutical and Medtech companies. We also welcome attendees from the NHS. Some colleagues from other organisations may attend, at the discretion of Mtech Access.

This content was provided by Mtech Access – Powered by Petauri™

Company Details

 Latest Content from  Mtech Access – Powered by Petauri™ 

Mtech Access have joined Petauri!

Mtech Access are now part of Petauri. This marks a significant and exciting milestone in our journey, and aligns with our commitment to partnering with industry to bring life-enhancing technologies...

De-mystifying the NHS – What you need to know about the NHS as a market for your health technology

Are you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibility for bringing a...

NHS primary care panel – the GP Contract and Operational Planning Guidance – Live Webinar

What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future...

The role of economic evaluation in US healthcare

Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US. They highlight important considerations for companies seeking...

What role does ICER play in US market access?

The Institute for Clinical and Economic Review (ICER) is becoming an increasingly important player in US market access. As more transformative, but costly, treatments come to market, payers must continue...

Mtech Access are exhibiting at ISPOR in the US

After many years attending ISPOR Europe, Mtech Access are excited to be attending the Global ISPOR conference May 5-8. Mtech Access are inviting ISPOR delegates to come by stand 125...

Market access and reimbursement in Canada – changes at CADTH

What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health...

Top 10 HEOR trends – A detailed look at ISPOR’s 2024–2025 topics

Specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024–2025. Jump in as the Mtech Access experts give their hot take on each...

Rare disease market access – Launching orphan drugs in secondary markets: the Nordic and MENA regions

Join us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thursday 29th February, to explore rare disease market access challenges and learn more about these high potential markets.

The pitfalls of cutting costs on systematic literature reviews: 11 common issues to avoid

Embarking on a systematic literature review is a critical step in evidence synthesis, providing a foundation for robust decision-making in the healthcare landscape. As with most things, there are ways...